secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2025-05-09T23:59:59+00:00
Accession:  0001093557-25-000129
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom stockholders approve equity plan share increases and elect directors
---------------------------------------------------------------------------

- Stockholders approved 3.4M new shares under Amended & Restated 2015 Equity Incentive Plan.
- Stockholders approved 8M new shares under Amended & Restated 2015 Employee Stock Purchase Plan.
- Board size reduced to 9 directors effective May 8, 2025.
- All nine director nominees elected, including Kevin Sayer and Steven R. Altman.
- Ratified Deloitte & Touche as independent auditor for fiscal year 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000129/0001093557-25-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355725000129/dxcm-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001093557-25-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer